Impact of CD4 + T-cell count on the performance of non-invasive fibrosis markers in HIV-HCV patients

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 10, 2011, Pages 1173-1174

  Schiavon, L L ^a   Narciso Schiavon, J L ^a   Carvalho Filho, R J ^a   Ferraz, M L G ^a   Silva, A E B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; APRI MODEL; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FIB4 MODEL; FIBROSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; LETTER; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MIXED INFECTION; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDITY;

ASPARTATE AMINOTRANSFERASES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PLATELET COUNT;

EID: 79954624845     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04613.x     Document Type: Letter

References (2)

1. Singal AG, Thomassen LV, Gretch DR, Shuhart MC,. Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther 2011; 33: 566-77.
2. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, et al. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int 2008; 28: 486-93. (Pubitemid 351411134)